Amgen Declares Fourth Quarter Dividend of $2.52 Per Share
Amgen has announced a cash dividend of $2.52 per share for the fourth quarter of 2026, payable to shareholders of record in December.
Amgen’s board of directors has authorized a quarterly cash dividend of $2.52 per share for the fourth quarter of 2026. This payment follows the biotechnology firm's established capital allocation strategy.
The dividend is scheduled for distribution on December 11, 2026. Shareholders of record at the close of business on the established record date will be eligible for the payment.
This dividend announcement maintains Amgen's recent commitment to returning capital to investors as the company continues to manage its portfolio of biologic therapies and navigate competitive pressures within the biopharmaceutical sector.